Alpine Global Management LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund bought 3,668 shares of the company’s stock, valued at approximately $272,000.
A number of other institutional investors have also recently added to or reduced their stakes in the business. Capital World Investors bought a new stake in Astera Labs during the 1st quarter worth approximately $44,514,000. Capital Research Global Investors bought a new stake in Astera Labs during the 1st quarter worth approximately $22,257,000. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Astera Labs during the 1st quarter worth approximately $1,484,000. Vanguard Group Inc. bought a new stake in Astera Labs during the 1st quarter worth approximately $127,268,000. Finally, Forge First Asset Management Inc. bought a new stake in shares of Astera Labs in the 1st quarter valued at $1,143,000.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on ALAB. Roth Mkm began coverage on shares of Astera Labs in a research note on Monday, April 15th. They issued a “buy” rating and a $85.00 price objective on the stock. Deutsche Bank Aktiengesellschaft began coverage on shares of Astera Labs in a research note on Monday, April 15th. They issued a “buy” rating and a $85.00 price objective on the stock. Evercore ISI began coverage on shares of Astera Labs in a research note on Tuesday, April 16th. They issued an “outperform” rating and a $100.00 price objective on the stock. Craig Hallum began coverage on shares of Astera Labs in a research note on Monday, April 15th. They issued a “buy” rating and a $90.00 price objective on the stock. Finally, Morgan Stanley began coverage on shares of Astera Labs in a research note on Monday, April 15th. They issued an “overweight” rating and a $81.00 price objective on the stock. Eleven analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $86.09.
Astera Labs Price Performance
Astera Labs stock traded up $0.09 during mid-day trading on Friday, hitting $47.14. 1,825,349 shares of the company traded hands, compared to its average volume of 1,360,609. Astera Labs, Inc. has a one year low of $45.41 and a one year high of $95.21. The business’s fifty day moving average price is $60.96.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its earnings results on Tuesday, May 7th. The company reported ($1.76) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($1.62). The business had revenue of $65.26 million for the quarter, compared to analyst estimates of $56.65 million. As a group, research analysts anticipate that Astera Labs, Inc. will post -0.56 earnings per share for the current year.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Recommended Stories
- Five stocks we like better than Astera Labs
- What is the FTSE 100 index?
- Is Crypto Cool Again? What Stocks You Should Be Watching
- What Makes a Stock a Good Dividend Stock?
- Why Call Options Volume for These 2 Stocks Spiked Together
- The 3 Best Retail Stocks to Shop for in August
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.